Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
AstraZeneca
Fish and Richardson
US Department of Justice
Queensland Health
Cipla

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,338,968

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,338,968
Title:Thiadiazoles AS CXC- and CC- chemokine receptor ligands
Abstract: Disclosed are novel compounds of the formula: ##STR00001## and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and ischemia reperfusion injury, pain (e.g., acute pain, acute and chronic inflammatory pain, and neuropathic pain) using a compound of formula IA.
Inventor(s): Biju; Purakkattle J. (Scotch Plains, NJ), Taveras; Arthur G. (Southborough, MA), Merritt; J. Robert (Ewing, NJ), Baldwin; John J. (Gwynedd Valley, PA), Yu; Younong (East Brunswick, NJ), Zheng; Junying (Bridgewater, NJ), Chao; Jianhua (Pompton Lakes, NJ), Aki; Cynthia J. (Livingston, NJ)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:11/013,753
Patent Claims:see list of patent claims

Details for Patent 7,338,968

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2023-12-19 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2023-12-19 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2023-12-19 RX search
Centocor Inc REOPRO abciximab INJECTABLE; INJECTION 103575 001 1994-12-22   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2023-12-19 RX search
Genentech TNKASE tenecteplase VIAL 103909 001 2000-06-02   Try a Free Trial Schering Corporation (Kenilworth, NJ) 2023-12-19 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Cipla
US Army
Chinese Patent Office
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.